AU2021236763A1 - Extracellular vesicles for therapy - Google Patents

Info

Publication number

AU2021236763A1

AU2021236763A1 AU2021236763A AU2021236763A AU2021236763A1 AU 2021236763 A1 AU2021236763 A1 AU 2021236763A1 AU 2021236763 A AU2021236763 A AU 2021236763A AU 2021236763 A AU2021236763 A AU 2021236763A AU 2021236763 A1 AU2021236763 A1 AU 2021236763A1

Authority

AU

Australia

Prior art keywords

antigen

scaffold

linked

moiety

aspects

Prior art date

2020-03-20

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• Discuss

• 238000002560 therapeutic procedure Methods 0.000 title description 4
• 239000000427 antigen Substances 0.000 claims abstract description 932
• 108091007433 antigens Proteins 0.000 claims abstract description 931
• 102000036639 antigens Human genes 0.000 claims abstract description 930
• 239000002671 adjuvant Substances 0.000 claims abstract description 266
• 241000711573 Coronaviridae Species 0.000 claims abstract description 141
• 241001678559 COVID-19 virus Species 0.000 claims abstract description 105
• 241000315672 SARS coronavirus Species 0.000 claims abstract description 96
• 238000000034 method Methods 0.000 claims abstract description 73
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 43
• 201000010099 disease Diseases 0.000 claims abstract description 29
• 208000035475 disorder Diseases 0.000 claims abstract description 14
• 108090000623 proteins and genes Proteins 0.000 claims description 148
• 210000004027 cell Anatomy 0.000 claims description 143
• 102000004169 proteins and genes Human genes 0.000 claims description 143
• 235000018102 proteins Nutrition 0.000 claims description 142
• 241000700605 Viruses Species 0.000 claims description 112
• 230000008685 targeting Effects 0.000 claims description 98
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 92
• 150000001413 amino acids Chemical class 0.000 claims description 84
• 235000001014 amino acid Nutrition 0.000 claims description 81
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 81
• 230000028993 immune response Effects 0.000 claims description 69
• 229940044665 STING agonist Drugs 0.000 claims description 63
• 210000001808 exosome Anatomy 0.000 claims description 60
• 239000000556 agonist Substances 0.000 claims description 59
• 210000004443 dendritic cell Anatomy 0.000 claims description 53
• 102100020864 Prostaglandin F2 receptor negative regulator Human genes 0.000 claims description 52
• 101710116300 Prostaglandin F2 receptor negative regulator Proteins 0.000 claims description 50
• 230000027455 binding Effects 0.000 claims description 45
• 238000011068 loading method Methods 0.000 claims description 44
• 238000004519 manufacturing process Methods 0.000 claims description 39
• 229960005486 vaccine Drugs 0.000 claims description 37
• 101000643024 Homo sapiens Stimulator of interferon genes protein Proteins 0.000 claims description 36
• 102100035533 Stimulator of interferon genes protein Human genes 0.000 claims description 36
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 35
• 239000003446 ligand Substances 0.000 claims description 34
• 239000012528 membrane Substances 0.000 claims description 34
• -1 single-stranded RNA Chemical compound 0.000 claims description 34
• 210000003719 b-lymphocyte Anatomy 0.000 claims description 30
• 102000005962 receptors Human genes 0.000 claims description 29
• 108020003175 receptors Proteins 0.000 claims description 29
• 238000004873 anchoring Methods 0.000 claims description 28
• 239000003795 chemical substances by application Substances 0.000 claims description 27
• 230000001939 inductive effect Effects 0.000 claims description 25
• 239000003550 marker Substances 0.000 claims description 23
• 229920001184 polypeptide Polymers 0.000 claims description 23
• 102100031673 Corneodesmosin Human genes 0.000 claims description 22
• 101710139375 Corneodesmosin Proteins 0.000 claims description 22
• 101150035137 Clec9a gene Proteins 0.000 claims description 21
• XDMCWZFLLGVIID-SXPRBRBTSA-N O-(3-O-D-galactosyl-N-acetyl-beta-D-galactosaminyl)-L-serine Chemical compound CC(=O)N[C@H]1[C@H](OC[C@H]([NH3+])C([O-])=O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 XDMCWZFLLGVIID-SXPRBRBTSA-N 0.000 claims description 21
• 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 claims description 21
• 230000021615 conjugation Effects 0.000 claims description 21
• 125000004122 cyclic group Chemical group 0.000 claims description 19
• 210000003071 memory t lymphocyte Anatomy 0.000 claims description 19
• 230000024932 T cell mediated immunity Effects 0.000 claims description 17
• 230000028996 humoral immune response Effects 0.000 claims description 16
• 210000005134 plasmacytoid dendritic cell Anatomy 0.000 claims description 15
• 101710085938 Matrix protein Proteins 0.000 claims description 14
• 101710127721 Membrane protein Proteins 0.000 claims description 14
• 239000000126 substance Substances 0.000 claims description 14
• 101710204837 Envelope small membrane protein Proteins 0.000 claims description 13
• 101710145006 Lysis protein Proteins 0.000 claims description 13
• 102100028252 Brain acid soluble protein 1 Human genes 0.000 claims description 12
• 101001059479 Homo sapiens Myristoylated alanine-rich C-kinase substrate Proteins 0.000 claims description 12
• 102100028903 Myristoylated alanine-rich C-kinase substrate Human genes 0.000 claims description 12
• 239000002158 endotoxin Substances 0.000 claims description 12
• 102100025354 Macrophage mannose receptor 1 Human genes 0.000 claims description 11
• 102000002689 Toll-like receptor Human genes 0.000 claims description 11
• 108020000411 Toll-like receptor Proteins 0.000 claims description 11
• 229920006008 lipopolysaccharide Polymers 0.000 claims description 11
• 150000007523 nucleic acids Chemical group 0.000 claims description 11
• 241000894006 Bacteria Species 0.000 claims description 10
• 101710087660 Brain acid soluble protein 1 Proteins 0.000 claims description 10
• 102100022516 Immunoglobulin superfamily member 2 Human genes 0.000 claims description 10
• 102100022519 Immunoglobulin superfamily member 3 Human genes 0.000 claims description 10
• 102100036489 Immunoglobulin superfamily member 8 Human genes 0.000 claims description 10
• 102100032818 Integrin alpha-4 Human genes 0.000 claims description 10
• 108091006313 SLC3A2 Proteins 0.000 claims description 10
• 230000005867 T cell response Effects 0.000 claims description 10
• 210000001519 tissue Anatomy 0.000 claims description 10
• 108010064528 Basigin Proteins 0.000 claims description 9
• 102100039521 C-type lectin domain family 9 member A Human genes 0.000 claims description 9
• 101710181540 Immunoglobulin superfamily member 2 Proteins 0.000 claims description 9
• 101710181459 Immunoglobulin superfamily member 3 Proteins 0.000 claims description 9
• 101710181535 Immunoglobulin superfamily member 8 Proteins 0.000 claims description 9
• 108010041012 Integrin alpha4 Proteins 0.000 claims description 9
• 102000012355 Integrin beta1 Human genes 0.000 claims description 9
• 108010022222 Integrin beta1 Proteins 0.000 claims description 9
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 8
• 208000025721 COVID-19 Diseases 0.000 claims description 8
• 108010051109 Cell-Penetrating Peptides Proteins 0.000 claims description 8
• 102000020313 Cell-Penetrating Peptides Human genes 0.000 claims description 8
• 108010031099 Mannose Receptor Proteins 0.000 claims description 8
• 102100033400 4F2 cell-surface antigen heavy chain Human genes 0.000 claims description 7
• 102100028667 C-type lectin domain family 4 member A Human genes 0.000 claims description 7
• 101710183461 C-type lectin domain family 4 member A Proteins 0.000 claims description 7
• 102100040840 C-type lectin domain family 7 member A Human genes 0.000 claims description 7
• 101000728117 Homo sapiens Plasma membrane calcium-transporting ATPase 4 Proteins 0.000 claims description 7
• 102100029743 Plasma membrane calcium-transporting ATPase 4 Human genes 0.000 claims description 7
• 108010025838 dectin 1 Proteins 0.000 claims description 7
• 239000003814 drug Substances 0.000 claims description 7
• 230000001965 increasing effect Effects 0.000 claims description 7
• 102100028681 C-type lectin domain family 4 member K Human genes 0.000 claims description 6
• 108010078791 Carrier Proteins Proteins 0.000 claims description 6
• 102100035294 Chemokine XC receptor 1 Human genes 0.000 claims description 6
• 241001502567 Chikungunya virus Species 0.000 claims description 6
• 208000000307 Crimean Hemorrhagic Fever Diseases 0.000 claims description 6
• 201000003075 Crimean-Congo hemorrhagic fever Diseases 0.000 claims description 6
• 241000893570 Hendra henipavirus Species 0.000 claims description 6
• 241000711549 Hepacivirus C Species 0.000 claims description 6
• 101000804783 Homo sapiens Chemokine XC receptor 1 Proteins 0.000 claims description 6
• 241000725303 Human immunodeficiency virus Species 0.000 claims description 6
• 241000701806 Human papillomavirus Species 0.000 claims description 6
• 241000187479 Mycobacterium tuberculosis Species 0.000 claims description 6
• 206010028980 Neoplasm Diseases 0.000 claims description 6
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 6
• 241000725643 Respiratory syncytial virus Species 0.000 claims description 6
• 208000000705 Rift Valley Fever Diseases 0.000 claims description 6
• 239000002253 acid Substances 0.000 claims description 6
• 208000015181 infectious disease Diseases 0.000 claims description 6
• 230000002757 inflammatory effect Effects 0.000 claims description 6
• 244000045947 parasite Species 0.000 claims description 6
• 230000037452 priming Effects 0.000 claims description 6
• 102100028668 C-type lectin domain family 4 member C Human genes 0.000 claims description 5
• 101150013553 CD40 gene Proteins 0.000 claims description 5
• 241000494545 Cordyline virus 2 Species 0.000 claims description 5
• 108010067306 Fibronectins Proteins 0.000 claims description 5
• 101000766907 Homo sapiens C-type lectin domain family 4 member C Proteins 0.000 claims description 5
• 101000728095 Homo sapiens Plasma membrane calcium-transporting ATPase 1 Proteins 0.000 claims description 5
• 101000728125 Homo sapiens Plasma membrane calcium-transporting ATPase 2 Proteins 0.000 claims description 5
• 101000728115 Homo sapiens Plasma membrane calcium-transporting ATPase 3 Proteins 0.000 claims description 5
• 101000701334 Homo sapiens Sodium/potassium-transporting ATPase subunit alpha-1 Proteins 0.000 claims description 5
• 101000753197 Homo sapiens Sodium/potassium-transporting ATPase subunit alpha-2 Proteins 0.000 claims description 5
• 101000753174 Homo sapiens Sodium/potassium-transporting ATPase subunit alpha-4 Proteins 0.000 claims description 5
• 101000974834 Homo sapiens Sodium/potassium-transporting ATPase subunit beta-3 Proteins 0.000 claims description 5
• 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 claims description 5
• 102000016943 Muramidase Human genes 0.000 claims description 5
• 108010014251 Muramidase Proteins 0.000 claims description 5
• 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 5
• 102100028762 Neuropilin-1 Human genes 0.000 claims description 5
• 102100029751 Plasma membrane calcium-transporting ATPase 1 Human genes 0.000 claims description 5
• 102100029744 Plasma membrane calcium-transporting ATPase 3 Human genes 0.000 claims description 5
• 102100030458 Sodium/potassium-transporting ATPase subunit alpha-1 Human genes 0.000 claims description 5
• 102100021955 Sodium/potassium-transporting ATPase subunit alpha-2 Human genes 0.000 claims description 5
• 102100021951 Sodium/potassium-transporting ATPase subunit alpha-4 Human genes 0.000 claims description 5
• 102100022792 Sodium/potassium-transporting ATPase subunit beta-3 Human genes 0.000 claims description 5
• 102100039360 Toll-like receptor 4 Human genes 0.000 claims description 5
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims description 5
• 210000003595 dermal dendritic cell Anatomy 0.000 claims description 5
• 210000002074 inflammatory monocyte Anatomy 0.000 claims description 5
• 210000001865 kupffer cell Anatomy 0.000 claims description 5
• 210000001821 langerhans cell Anatomy 0.000 claims description 5
• 239000004325 lysozyme Substances 0.000 claims description 5
• 235000010335 lysozyme Nutrition 0.000 claims description 5
• 229960000274 lysozyme Drugs 0.000 claims description 5
• 229940044655 toll-like receptor 9 agonist Drugs 0.000 claims description 5
• 102100040839 C-type lectin domain family 6 member A Human genes 0.000 claims description 4
• 101710125370 C-type lectin domain family 6 member A Proteins 0.000 claims description 4
• 101710163666 C-type lectin domain family 9 member A Proteins 0.000 claims description 4
• 208000035473 Communicable disease Diseases 0.000 claims description 4
• 241000588724 Escherichia coli Species 0.000 claims description 4
• 241000233866 Fungi Species 0.000 claims description 4
• 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 claims description 4
• 102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 claims description 4
• 108010090804 Streptavidin Proteins 0.000 claims description 4
• 230000001413 cellular effect Effects 0.000 claims description 4
• 102000006495 integrins Human genes 0.000 claims description 4
• 108010044426 integrins Proteins 0.000 claims description 4
• 230000017730 intein-mediated protein splicing Effects 0.000 claims description 4
• 230000002829 reductive effect Effects 0.000 claims description 4
• 229940124597 therapeutic agent Drugs 0.000 claims description 4
• 239000013598 vector Substances 0.000 claims description 4
• DMWMUMWKGKGSNW-OPMCLZTFSA-N (2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-4-amino-2-[[2-[[(2R)-2-amino-3-[(2R)-2,3-di(hexadecanoyloxy)propyl]sulfanylpropanoyl]amino]acetyl]amino]-4-oxobutanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]hexanoyl]amino]-4-carboxybutanoyl]amino]hexanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](CSC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(O)=O)OC(=O)CCCCCCCCCCCCCCC DMWMUMWKGKGSNW-OPMCLZTFSA-N 0.000 claims description 3
• FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 3
• 102000040650 (ribonucleotides)n+m Human genes 0.000 claims description 3
• FBFJOZZTIXSPPR-UHFFFAOYSA-N 1-(4-aminobutyl)-2-(ethoxymethyl)imidazo[4,5-c]quinolin-4-amine Chemical compound C1=CC=CC2=C(N(C(COCC)=N3)CCCCN)C3=C(N)N=C21 FBFJOZZTIXSPPR-UHFFFAOYSA-N 0.000 claims description 3
• ZPDQFUYPBVXUKS-YADHBBJMSA-N 1-stearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(O)(=O)OC[C@H](N)C(O)=O ZPDQFUYPBVXUKS-YADHBBJMSA-N 0.000 claims description 3
• 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims description 3
• 101100339431 Arabidopsis thaliana HMGB2 gene Proteins 0.000 claims description 3
• 244000063299 Bacillus subtilis Species 0.000 claims description 3
• 235000014469 Bacillus subtilis Nutrition 0.000 claims description 3
• 229920002498 Beta-glucan Polymers 0.000 claims description 3
• 241000589969 Borreliella burgdorferi Species 0.000 claims description 3
• 241000589562 Brucella Species 0.000 claims description 3
• 108090000342 C-Type Lectins Proteins 0.000 claims description 3
• 102000003930 C-Type Lectins Human genes 0.000 claims description 3
• 101710183165 C-type lectin domain family 4 member K Proteins 0.000 claims description 3
• 102100021992 CD209 antigen Human genes 0.000 claims description 3
• 108090000835 CX3C Chemokine Receptor 1 Proteins 0.000 claims description 3
• 102100039196 CX3C chemokine receptor 1 Human genes 0.000 claims description 3
• 241000589875 Campylobacter jejuni Species 0.000 claims description 3
• 101710163595 Chaperone protein DnaK Proteins 0.000 claims description 3
• 102000006303 Chaperonin 60 Human genes 0.000 claims description 3
• 108010058432 Chaperonin 60 Proteins 0.000 claims description 3
• 229920002101 Chitin Polymers 0.000 claims description 3
• 241000606161 Chlamydia Species 0.000 claims description 3
• 241000606153 Chlamydia trachomatis Species 0.000 claims description 3
• 102000050083 Class E Scavenger Receptors Human genes 0.000 claims description 3
• 241001112696 Clostridia Species 0.000 claims description 3
• 241000193403 Clostridium Species 0.000 claims description 3
• 241000193468 Clostridium perfringens Species 0.000 claims description 3
• 241000186216 Corynebacterium Species 0.000 claims description 3
• 241000223935 Cryptosporidium Species 0.000 claims description 3
• 229920002558 Curdlan Polymers 0.000 claims description 3
• 239000001879 Curdlan Substances 0.000 claims description 3
• 208000001490 Dengue Diseases 0.000 claims description 3
• 206010012310 Dengue fever Diseases 0.000 claims description 3
• 241001115402 Ebolavirus Species 0.000 claims description 3
• 102100037354 Ectodysplasin-A Human genes 0.000 claims description 3
• 241000224431 Entamoeba Species 0.000 claims description 3
• 241000709661 Enterovirus Species 0.000 claims description 3
• 241000711950 Filoviridae Species 0.000 claims description 3
• 108010040721 Flagellin Proteins 0.000 claims description 3
• 241000710831 Flavivirus Species 0.000 claims description 3
• 102100021243 G-protein coupled receptor 182 Human genes 0.000 claims description 3
• 102000003886 Glycoproteins Human genes 0.000 claims description 3
• 108090000288 Glycoproteins Proteins 0.000 claims description 3
• 108700010013 HMGB1 Proteins 0.000 claims description 3
• 101150021904 HMGB1 gene Proteins 0.000 claims description 3
• 241000606768 Haemophilus influenzae Species 0.000 claims description 3
• 101710178376 Heat shock 70 kDa protein Proteins 0.000 claims description 3
• 101710152018 Heat shock cognate 70 kDa protein Proteins 0.000 claims description 3
• 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 3
• 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 3
• 102000052923 Heavy Chain Fusion Regulatory Protein 1 Human genes 0.000 claims description 3
• 101710154606 Hemagglutinin Proteins 0.000 claims description 3
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 3
• 102100037907 High mobility group protein B1 Human genes 0.000 claims description 3
• 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims description 3
• 101000897416 Homo sapiens CD209 antigen Proteins 0.000 claims description 3
• 101000880080 Homo sapiens Ectodysplasin-A Proteins 0.000 claims description 3
• 101001040797 Homo sapiens G-protein coupled receptor 182 Proteins 0.000 claims description 3
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 3
• 101000917826 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-a Proteins 0.000 claims description 3
• 101000917824 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-b Proteins 0.000 claims description 3
• 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 claims description 3
• 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 claims description 3
• 101000576894 Homo sapiens Macrophage mannose receptor 1 Proteins 0.000 claims description 3
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims description 3
• 101000577540 Homo sapiens Neuropilin-1 Proteins 0.000 claims description 3
• 101000863880 Homo sapiens Sialic acid-binding Ig-like lectin 6 Proteins 0.000 claims description 3
• 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 claims description 3
• 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 claims description 3
• 101000669460 Homo sapiens Toll-like receptor 5 Proteins 0.000 claims description 3
• 101000669406 Homo sapiens Toll-like receptor 6 Proteins 0.000 claims description 3
• 101000807561 Homo sapiens Tyrosine-protein kinase receptor UFO Proteins 0.000 claims description 3
• 101000863873 Homo sapiens Tyrosine-protein phosphatase non-receptor type substrate 1 Proteins 0.000 claims description 3
• 241000702617 Human parvovirus B19 Species 0.000 claims description 3
• 108010064600 Intercellular Adhesion Molecule-3 Proteins 0.000 claims description 3
• 102100037871 Intercellular adhesion molecule 3 Human genes 0.000 claims description 3
• 241000588747 Klebsiella pneumoniae Species 0.000 claims description 3
• 241000712902 Lassa mammarenavirus Species 0.000 claims description 3
• 241000222722 Leishmania <genus> Species 0.000 claims description 3
• 241000713666 Lentivirus Species 0.000 claims description 3
• 102100029204 Low affinity immunoglobulin gamma Fc region receptor II-a Human genes 0.000 claims description 3
• 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 claims description 3
• 102100033486 Lymphocyte antigen 75 Human genes 0.000 claims description 3
• 101710157884 Lymphocyte antigen 75 Proteins 0.000 claims description 3
• 241001115401 Marburgvirus Species 0.000 claims description 3
• 241000712079 Measles morbillivirus Species 0.000 claims description 3
• 201000009906 Meningitis Diseases 0.000 claims description 3
• 241000700627 Monkeypox virus Species 0.000 claims description 3
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims description 3
• 241000588655 Moraxella catarrhalis Species 0.000 claims description 3
• 101000944608 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Chaperonin GroEL 2 Proteins 0.000 claims description 3
• 108010063737 Myristoylated Alanine-Rich C Kinase Substrate Proteins 0.000 claims description 3
• 102000015695 Myristoylated Alanine-Rich C Kinase Substrate Human genes 0.000 claims description 3
• 241000588653 Neisseria Species 0.000 claims description 3
• 241000588652 Neisseria gonorrhoeae Species 0.000 claims description 3
• 241000526636 Nipah henipavirus Species 0.000 claims description 3
• 108700006640 OspA Proteins 0.000 claims description 3
• 101710093908 Outer capsid protein VP4 Proteins 0.000 claims description 3
• 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims description 3
• 102100025386 Oxidized low-density lipoprotein receptor 1 Human genes 0.000 claims description 3
• 101710199789 Oxidized low-density lipoprotein receptor 1 Proteins 0.000 claims description 3
• 241000224016 Plasmodium Species 0.000 claims description 3
• 108010013381 Porins Proteins 0.000 claims description 3
• 101710176177 Protein A56 Proteins 0.000 claims description 3
• 241000125945 Protoparvovirus Species 0.000 claims description 3
• 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 3
• 229940044606 RIG-I agonist Drugs 0.000 claims description 3
• 241000607142 Salmonella Species 0.000 claims description 3
• 241000242678 Schistosoma Species 0.000 claims description 3
• 241000607768 Shigella Species 0.000 claims description 3
• 102100029947 Sialic acid-binding Ig-like lectin 6 Human genes 0.000 claims description 3
• 102000008736 Snapin Human genes 0.000 claims description 3
• 108050000529 Snapin Proteins 0.000 claims description 3
• 241000191967 Staphylococcus aureus Species 0.000 claims description 3
• 241000194017 Streptococcus Species 0.000 claims description 3
• 241000193985 Streptococcus agalactiae Species 0.000 claims description 3
• 241000193998 Streptococcus pneumoniae Species 0.000 claims description 3
• 241000193996 Streptococcus pyogenes Species 0.000 claims description 3
• 229940124613 TLR 7/8 agonist Drugs 0.000 claims description 3
• 102000007000 Tenascin Human genes 0.000 claims description 3
• 108010008125 Tenascin Proteins 0.000 claims description 3
• 206010043376 Tetanus Diseases 0.000 claims description 3
• 229940123384 Toll-like receptor (TLR) agonist Drugs 0.000 claims description 3
• 102100024333 Toll-like receptor 2 Human genes 0.000 claims description 3
• 102100024324 Toll-like receptor 3 Human genes 0.000 claims description 3
• 102100039357 Toll-like receptor 5 Human genes 0.000 claims description 3
• 102100039387 Toll-like receptor 6 Human genes 0.000 claims description 3
• 241000589884 Treponema pallidum Species 0.000 claims description 3
• 241000223104 Trypanosoma Species 0.000 claims description 3
• 102100037236 Tyrosine-protein kinase receptor UFO Human genes 0.000 claims description 3
• 102100029948 Tyrosine-protein phosphatase non-receptor type substrate 1 Human genes 0.000 claims description 3
• 241000700647 Variola virus Species 0.000 claims description 3
• 241000607626 Vibrio cholerae Species 0.000 claims description 3
• 241000710772 Yellow fever virus Species 0.000 claims description 3
• 241000607479 Yersinia pestis Species 0.000 claims description 3
• 241000907316 Zika virus Species 0.000 claims description 3
• 229920000392 Zymosan Polymers 0.000 claims description 3
• 239000013566 allergen Substances 0.000 claims description 3
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
• 229940038705 chlamydia trachomatis Drugs 0.000 claims description 3
• 235000019316 curdlan Nutrition 0.000 claims description 3
• 229940078035 curdlan Drugs 0.000 claims description 3
• 208000025729 dengue disease Diseases 0.000 claims description 3
• 229940079593 drug Drugs 0.000 claims description 3
• 239000000185 hemagglutinin Substances 0.000 claims description 3
• 108010051618 macrophage stimulatory lipopeptide 2 Proteins 0.000 claims description 3
• 239000008194 pharmaceutical composition Substances 0.000 claims description 3
• 102000007739 porin activity proteins Human genes 0.000 claims description 3
• BXNMTOQRYBFHNZ-UHFFFAOYSA-N resiquimod Chemical compound C1=CC=CC2=C(N(C(COCC)=N3)CC(C)(C)O)C3=C(N)N=C21 BXNMTOQRYBFHNZ-UHFFFAOYSA-N 0.000 claims description 3
• 229950010550 resiquimod Drugs 0.000 claims description 3
• 108091005418 scavenger receptor class E Proteins 0.000 claims description 3
• 229940031000 streptococcus pneumoniae Drugs 0.000 claims description 3
• 241000701161 unidentified adenovirus Species 0.000 claims description 3
• 241000712461 unidentified influenza virus Species 0.000 claims description 3
• 229940051021 yellow-fever virus Drugs 0.000 claims description 3
• 238000012258 culturing Methods 0.000 claims description 2
• 239000003937 drug carrier Substances 0.000 claims description 2
• 230000006698 induction Effects 0.000 claims description 2
• 229940023041 peptide vaccine Drugs 0.000 claims description 2
• 102100032412 Basigin Human genes 0.000 claims 2
• 101000935689 Homo sapiens Brain acid soluble protein 1 Proteins 0.000 claims 2
• 101000931590 Homo sapiens Prostaglandin F2 receptor negative regulator Proteins 0.000 claims 2
• 101150033066 CD101 gene Proteins 0.000 claims 1
• 102000016359 Fibronectins Human genes 0.000 claims 1
• 101000994375 Homo sapiens Integrin alpha-4 Proteins 0.000 claims 1
• 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 claims 1
• 101001014572 Homo sapiens MARCKS-related protein Proteins 0.000 claims 1
• 101150091468 IGSF8 gene Proteins 0.000 claims 1
• 101150018316 Igsf3 gene Proteins 0.000 claims 1
• 102100025304 Integrin beta-1 Human genes 0.000 claims 1
• 102100032514 MARCKS-related protein Human genes 0.000 claims 1
• 101710196623 Stimulator of interferon genes protein Proteins 0.000 claims 1
• 229940024606 amino acid Drugs 0.000 description 68
• 239000012634 fragment Substances 0.000 description 52
• 101710198474 Spike protein Proteins 0.000 description 43
• 229940096437 Protein S Drugs 0.000 description 42
• 230000014509 gene expression Effects 0.000 description 33
• 210000004379 membrane Anatomy 0.000 description 32
• 241001465754 Metazoa Species 0.000 description 26
• 230000004048 modification Effects 0.000 description 25
• 238000012986 modification Methods 0.000 description 25
• 239000000203 mixture Substances 0.000 description 23
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 22
• 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 22
• 150000002632 lipids Chemical class 0.000 description 18
• 108091005634 SARS-CoV-2 receptor-binding domains Proteins 0.000 description 17
• 210000002865 immune cell Anatomy 0.000 description 17
• 108700043045 nanoluc Proteins 0.000 description 17
• 150000003839 salts Chemical class 0.000 description 17
• 238000011282 treatment Methods 0.000 description 17
• 108010061994 Coronavirus Spike Glycoprotein Proteins 0.000 description 16
• 108010058846 Ovalbumin Proteins 0.000 description 15
• 239000012636 effector Substances 0.000 description 15
• 229940092253 ovalbumin Drugs 0.000 description 15
• 108091054437 MHC class I family Proteins 0.000 description 14
• 238000010586 diagram Methods 0.000 description 14
• 238000009826 distribution Methods 0.000 description 13
• 230000004927 fusion Effects 0.000 description 13
• 125000003729 nucleotide group Chemical group 0.000 description 13
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 12
• 230000004913 activation Effects 0.000 description 12
• 238000007792 addition Methods 0.000 description 12
• 230000001404 mediated effect Effects 0.000 description 12
• 239000002773 nucleotide Substances 0.000 description 12
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 12
• 108010088652 Histocompatibility Antigens Class I Proteins 0.000 description 11
• 102000043129 MHC class I family Human genes 0.000 description 11
• 102000043131 MHC class II family Human genes 0.000 description 11
• 108091054438 MHC class II family Proteins 0.000 description 11
• 108091008874 T cell receptors Proteins 0.000 description 11
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 11
• 125000003275 alpha amino acid group Chemical group 0.000 description 11
• 238000005538 encapsulation Methods 0.000 description 11
• 229940046168 CpG oligodeoxynucleotide Drugs 0.000 description 10
• 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 10
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 10
• 150000001720 carbohydrates Chemical class 0.000 description 10
• 235000014633 carbohydrates Nutrition 0.000 description 10
• 230000000875 corresponding effect Effects 0.000 description 10
• 230000000694 effects Effects 0.000 description 10
• 150000003384 small molecules Chemical class 0.000 description 10
• 239000004472 Lysine Substances 0.000 description 9
• 210000000612 antigen-presenting cell Anatomy 0.000 description 9
• 108020001507 fusion proteins Proteins 0.000 description 9
• 102000037865 fusion proteins Human genes 0.000 description 9
• 230000004044 response Effects 0.000 description 9
• 230000010415 tropism Effects 0.000 description 9
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 8
• 102000015279 Basigin Human genes 0.000 description 8
• 102000004127 Cytokines Human genes 0.000 description 8
• 108090000695 Cytokines Proteins 0.000 description 8
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 8
• 108091034117 Oligonucleotide Proteins 0.000 description 8
• 101500027983 Rattus norvegicus Octadecaneuropeptide Proteins 0.000 description 8
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 8
• 230000000670 limiting effect Effects 0.000 description 8
• 210000004072 lung Anatomy 0.000 description 8
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 8
• 102000039446 nucleic acids Human genes 0.000 description 8
• 108020004707 nucleic acids Proteins 0.000 description 8
• 229940046166 oligodeoxynucleotide Drugs 0.000 description 8
• 102000040430 polynucleotide Human genes 0.000 description 8
• 108091033319 polynucleotide Proteins 0.000 description 8
• 239000002157 polynucleotide Substances 0.000 description 8
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 7
• 108091028732 Concatemer Proteins 0.000 description 7
• 108020004414 DNA Proteins 0.000 description 7
• 125000000539 amino acid group Chemical group 0.000 description 7
• 210000000170 cell membrane Anatomy 0.000 description 7
• 230000001086 cytosolic effect Effects 0.000 description 7
• 210000000987 immune system Anatomy 0.000 description 7
• 229940127121 immunoconjugate Drugs 0.000 description 7
• 239000000047 product Substances 0.000 description 7
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 7
• 241000894007 species Species 0.000 description 7
• 239000003053 toxin Substances 0.000 description 7
• 231100000765 toxin Toxicity 0.000 description 7
• 108700012359 toxins Proteins 0.000 description 7
• 101710167800 Capsid assembly scaffolding protein Proteins 0.000 description 6
• 102000004190 Enzymes Human genes 0.000 description 6
• 108090000790 Enzymes Proteins 0.000 description 6
• 241000282412 Homo Species 0.000 description 6
• 102100033467 L-selectin Human genes 0.000 description 6
• 102100038225 Lysosome-associated membrane glycoprotein 2 Human genes 0.000 description 6
• 108091008606 PDGF receptors Proteins 0.000 description 6
• 102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 description 6
• 101710130420 Probable capsid assembly scaffolding protein Proteins 0.000 description 6
• 101710204410 Scaffold protein Proteins 0.000 description 6
• 239000002585 base Substances 0.000 description 6
• 229940088598 enzyme Drugs 0.000 description 6
• 230000004576 lipid-binding Effects 0.000 description 6
• 210000002540 macrophage Anatomy 0.000 description 6
• 108020004999 messenger RNA Proteins 0.000 description 6
• 230000008569 process Effects 0.000 description 6
• 125000006850 spacer group Chemical group 0.000 description 6
• 230000001225 therapeutic effect Effects 0.000 description 6
• 239000003981 vehicle Substances 0.000 description 6
• 241000283690 Bos taurus Species 0.000 description 5
• 241000282472 Canis lupus familiaris Species 0.000 description 5
• 102100028976 HLA class I histocompatibility antigen, B alpha chain Human genes 0.000 description 5
• 101000888548 Homo sapiens C-type lectin domain family 9 member A Proteins 0.000 description 5
• 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 description 5
• 241000699666 Mus <mouse, genus> Species 0.000 description 5
• 108700026244 Open Reading Frames Proteins 0.000 description 5
• 241000700159 Rattus Species 0.000 description 5
• 101710086987 X protein Proteins 0.000 description 5
• 238000004458 analytical method Methods 0.000 description 5
• 229940049595 antibody-drug conjugate Drugs 0.000 description 5
• 238000003556 assay Methods 0.000 description 5
• 150000001875 compounds Chemical class 0.000 description 5
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 5
• 230000002401 inhibitory effect Effects 0.000 description 5
• 229920002521 macromolecule Polymers 0.000 description 5
• 239000000178 monomer Substances 0.000 description 5
• 210000000440 neutrophil Anatomy 0.000 description 5
• 244000052769 pathogen Species 0.000 description 5
• 239000002953 phosphate buffered saline Substances 0.000 description 5
• 238000002360 preparation method Methods 0.000 description 5
• 238000006467 substitution reaction Methods 0.000 description 5
• 238000005199 ultracentrifugation Methods 0.000 description 5
• 238000001262 western blot Methods 0.000 description 5
• 102100025222 CD63 antigen Human genes 0.000 description 4
• 102100027221 CD81 antigen Human genes 0.000 description 4
• 102100037904 CD9 antigen Human genes 0.000 description 4
• 102100037362 Fibronectin Human genes 0.000 description 4
• 108010027412 Histocompatibility Antigens Class II Proteins 0.000 description 4
• 102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 4
• 101000934368 Homo sapiens CD63 antigen Proteins 0.000 description 4
• 101000914479 Homo sapiens CD81 antigen Proteins 0.000 description 4
• 101000738354 Homo sapiens CD9 antigen Proteins 0.000 description 4
• 101001018097 Homo sapiens L-selectin Proteins 0.000 description 4
• 101000753178 Homo sapiens Sodium/potassium-transporting ATPase subunit alpha-3 Proteins 0.000 description 4
• 102100039648 Lactadherin Human genes 0.000 description 4
• 101710191666 Lactadherin Proteins 0.000 description 4
• 108010009491 Lysosomal-Associated Membrane Protein 2 Proteins 0.000 description 4
• 102100021952 Sodium/potassium-transporting ATPase subunit alpha-3 Human genes 0.000 description 4
• 150000001540 azides Chemical class 0.000 description 4
• 238000010170 biological method Methods 0.000 description 4
• 230000015572 biosynthetic process Effects 0.000 description 4
• 239000000562 conjugate Substances 0.000 description 4
• 210000003162 effector t lymphocyte Anatomy 0.000 description 4
• 210000001163 endosome Anatomy 0.000 description 4
• 238000005755 formation reaction Methods 0.000 description 4
• 230000006870 function Effects 0.000 description 4
• 238000010353 genetic engineering Methods 0.000 description 4
• 210000003630 histaminocyte Anatomy 0.000 description 4
• 230000017555 immunoglobulin mediated immune response Effects 0.000 description 4
• 238000000338 in vitro Methods 0.000 description 4
• 238000001727 in vivo Methods 0.000 description 4
• 230000003993 interaction Effects 0.000 description 4
• 230000007246 mechanism Effects 0.000 description 4
• 210000000822 natural killer cell Anatomy 0.000 description 4
• 230000037361 pathway Effects 0.000 description 4
• 150000003141 primary amines Chemical group 0.000 description 4
• 238000004445 quantitative analysis Methods 0.000 description 4
• 238000007920 subcutaneous administration Methods 0.000 description 4
• 238000002255 vaccination Methods 0.000 description 4
• NAGKYJATVFXZKN-UHFFFAOYSA-N 4-[(2-chloro-6-fluorophenyl)methyl]-n-(furan-2-ylmethyl)-3-oxo-1,4-benzothiazine-6-carboxamide Chemical compound FC1=CC=CC(Cl)=C1CN1C2=CC(C(=O)NCC=3OC=CC=3)=CC=C2SCC1=O NAGKYJATVFXZKN-UHFFFAOYSA-N 0.000 description 3
• 241000700198 Cavia Species 0.000 description 3
• 241000283086 Equidae Species 0.000 description 3
• 241000282326 Felis catus Species 0.000 description 3
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
• 101000936922 Homo sapiens Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 Proteins 0.000 description 3
• 101800000324 Immunoglobulin A1 protease translocator Proteins 0.000 description 3
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 3
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
• 108700011259 MicroRNAs Proteins 0.000 description 3
• 241000699670 Mus sp. Species 0.000 description 3
• 102100028782 Neprilysin Human genes 0.000 description 3
• 241000283973 Oryctolagus cuniculus Species 0.000 description 3
• 101150036449 SIRPA gene Proteins 0.000 description 3
• 102100027732 Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 Human genes 0.000 description 3
• 108020004459 Small interfering RNA Proteins 0.000 description 3
• 108700019146 Transgenes Proteins 0.000 description 3
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
• 230000002378 acidificating effect Effects 0.000 description 3
• 150000001345 alkine derivatives Chemical class 0.000 description 3
• 230000004075 alteration Effects 0.000 description 3
• AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 3
• 239000000611 antibody drug conjugate Substances 0.000 description 3
• 239000000074 antisense oligonucleotide Substances 0.000 description 3
• 238000012230 antisense oligonucleotides Methods 0.000 description 3
• 238000013459 approach Methods 0.000 description 3
• 230000009286 beneficial effect Effects 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 230000004071 biological effect Effects 0.000 description 3
• 210000004369 blood Anatomy 0.000 description 3
• 239000008280 blood Substances 0.000 description 3
• RFCBNSCSPXMEBK-INFSMZHSSA-N c-GMP-AMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]3[C@@H](O)[C@H](N4C5=NC=NC(N)=C5N=C4)O[C@@H]3COP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 RFCBNSCSPXMEBK-INFSMZHSSA-N 0.000 description 3
• 230000034303 cell budding Effects 0.000 description 3
• 230000006378 damage Effects 0.000 description 3
• 238000012217 deletion Methods 0.000 description 3
• 230000037430 deletion Effects 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• 235000014113 dietary fatty acids Nutrition 0.000 description 3
• 239000000839 emulsion Substances 0.000 description 3
• 238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 3
• 210000003979 eosinophil Anatomy 0.000 description 3
• 238000013401 experimental design Methods 0.000 description 3
• 229930195729 fatty acid Natural products 0.000 description 3
• 239000000194 fatty acid Substances 0.000 description 3
• 150000004665 fatty acids Chemical class 0.000 description 3
• 238000000684 flow cytometry Methods 0.000 description 3
• 125000000524 functional group Chemical group 0.000 description 3
• 150000004676 glycans Chemical class 0.000 description 3
• 210000002861 immature t-cell Anatomy 0.000 description 3
• 239000002955 immunomodulating agent Substances 0.000 description 3
• 229940121354 immunomodulator Drugs 0.000 description 3
• 230000005764 inhibitory process Effects 0.000 description 3
• 230000003834 intracellular effect Effects 0.000 description 3
• 238000002372 labelling Methods 0.000 description 3
• 210000002901 mesenchymal stem cell Anatomy 0.000 description 3
• 239000002679 microRNA Substances 0.000 description 3
• 238000002887 multiple sequence alignment Methods 0.000 description 3
• 210000003205 muscle Anatomy 0.000 description 3
• 230000035772 mutation Effects 0.000 description 3
• 150000003904 phospholipids Chemical class 0.000 description 3
• 238000000746 purification Methods 0.000 description 3
• 230000009467 reduction Effects 0.000 description 3
• 230000001105 regulatory effect Effects 0.000 description 3
• 238000002864 sequence alignment Methods 0.000 description 3
• 230000019491 signal transduction Effects 0.000 description 3
• 239000004055 small Interfering RNA Substances 0.000 description 3
• 210000000952 spleen Anatomy 0.000 description 3
• 230000004936 stimulating effect Effects 0.000 description 3
• 208000024891 symptom Diseases 0.000 description 3
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
• GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
• QRZUPJILJVGUFF-UHFFFAOYSA-N 2,8-dibenzylcyclooctan-1-one Chemical compound C1CCCCC(CC=2C=CC=CC=2)C(=O)C1CC1=CC=CC=C1 QRZUPJILJVGUFF-UHFFFAOYSA-N 0.000 description 2
• OUCMTIKCFRCBHK-UHFFFAOYSA-N 3,3-dibenzylcyclooctyne Chemical compound C1CCCCC#CC1(CC=1C=CC=CC=1)CC1=CC=CC=C1 OUCMTIKCFRCBHK-UHFFFAOYSA-N 0.000 description 2
• LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
• 102100037435 Antiviral innate immune response receptor RIG-I Human genes 0.000 description 2
• 102100038080 B-cell receptor CD22 Human genes 0.000 description 2
• 241000112287 Bat coronavirus Species 0.000 description 2
• 102000002086 C-type lectin-like Human genes 0.000 description 2
• 108050009406 C-type lectin-like Proteins 0.000 description 2
• 229940123189 CD40 agonist Drugs 0.000 description 2
• 108020004705 Codon Proteins 0.000 description 2
• 102000053602 DNA Human genes 0.000 description 2
• 241000283073 Equus caballus Species 0.000 description 2
• 108050001049 Extracellular proteins Proteins 0.000 description 2
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
• JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 2
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 2
• 101000952099 Homo sapiens Antiviral innate immune response receptor RIG-I Proteins 0.000 description 2
• 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 description 2
• 101001123834 Homo sapiens Neprilysin Proteins 0.000 description 2
• 108010044240 IFIH1 Interferon-Induced Helicase Proteins 0.000 description 2
• 229940076838 Immune checkpoint inhibitor Drugs 0.000 description 2
• 108060003951 Immunoglobulin Proteins 0.000 description 2
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
• 206010061218 Inflammation Diseases 0.000 description 2
• 102000002227 Interferon Type I Human genes 0.000 description 2
• 108010014726 Interferon Type I Proteins 0.000 description 2
• 102100027353 Interferon-induced helicase C domain-containing protein 1 Human genes 0.000 description 2
• 108010065805 Interleukin-12 Proteins 0.000 description 2
• 102000013691 Interleukin-17 Human genes 0.000 description 2
• 108050003558 Interleukin-17 Proteins 0.000 description 2
• 108090001005 Interleukin-6 Proteins 0.000 description 2
• 108010092694 L-Selectin Proteins 0.000 description 2
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
• 239000000232 Lipid Bilayer Substances 0.000 description 2
• 101710116771 Lysosome-associated membrane glycoprotein 2 Proteins 0.000 description 2
• 241000282560 Macaca mulatta Species 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• 108010052285 Membrane Proteins Proteins 0.000 description 2
• 208000025370 Middle East respiratory syndrome Diseases 0.000 description 2
• 108090000028 Neprilysin Proteins 0.000 description 2
• 108090000772 Neuropilin-1 Proteins 0.000 description 2
• 108090001074 Nucleocapsid Proteins Proteins 0.000 description 2
• 102100039306 Nucleotide pyrophosphatase Human genes 0.000 description 2
• 241000282577 Pan troglodytes Species 0.000 description 2
• 102000007079 Peptide Fragments Human genes 0.000 description 2
• 108010033276 Peptide Fragments Proteins 0.000 description 2
• 206010057249 Phagocytosis Diseases 0.000 description 2
• 101000779242 Severe acute respiratory syndrome coronavirus 2 ORF3a protein Proteins 0.000 description 2
• 101800001089 Spike protein S2' Proteins 0.000 description 2
• 230000006044 T cell activation Effects 0.000 description 2
• 108700031126 Tetraspanins Proteins 0.000 description 2
• 102000043977 Tetraspanins Human genes 0.000 description 2
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
• 239000004473 Threonine Substances 0.000 description 2
• 108010060818 Toll-Like Receptor 9 Proteins 0.000 description 2
• 102100033117 Toll-like receptor 9 Human genes 0.000 description 2
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
• 241000282458 Ursus sp. Species 0.000 description 2
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
• 208000036142 Viral infection Diseases 0.000 description 2
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
• 230000002159 abnormal effect Effects 0.000 description 2
• 239000012670 alkaline solution Substances 0.000 description 2
• 229940037003 alum Drugs 0.000 description 2
• 229910052782 aluminium Inorganic materials 0.000 description 2
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
• 239000005557 antagonist Substances 0.000 description 2
• 230000005875 antibody response Effects 0.000 description 2
• 230000008827 biological function Effects 0.000 description 2
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
• 235000012000 cholesterol Nutrition 0.000 description 2
• 229960001231 choline Drugs 0.000 description 2
• PDXMFTWFFKBFIN-XPWFQUROSA-N cyclic di-AMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]3[C@@H](O)[C@H](N4C5=NC=NC(N)=C5N=C4)O[C@@H]3COP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 PDXMFTWFFKBFIN-XPWFQUROSA-N 0.000 description 2
• ZPWOOKQUDFIEIX-UHFFFAOYSA-N cyclooctyne Chemical class C1CCCC#CCC1 ZPWOOKQUDFIEIX-UHFFFAOYSA-N 0.000 description 2
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
• 235000018417 cysteine Nutrition 0.000 description 2
• 210000004544 dc2 Anatomy 0.000 description 2
• 238000003745 diagnosis Methods 0.000 description 2
• 230000004069 differentiation Effects 0.000 description 2
• 239000000539 dimer Substances 0.000 description 2
• 208000037765 diseases and disorders Diseases 0.000 description 2
• 238000012377 drug delivery Methods 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 230000002708 enhancing effect Effects 0.000 description 2
• 238000001125 extrusion Methods 0.000 description 2
• 210000002950 fibroblast Anatomy 0.000 description 2
• 230000003325 follicular Effects 0.000 description 2
• 230000002068 genetic effect Effects 0.000 description 2
• 230000013595 glycosylation Effects 0.000 description 2
• 238000006206 glycosylation reaction Methods 0.000 description 2
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
• FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
• 239000012274 immune-checkpoint protein inhibitor Substances 0.000 description 2
• 230000036039 immunity Effects 0.000 description 2
• 230000003053 immunization Effects 0.000 description 2
• 238000002649 immunization Methods 0.000 description 2
• 102000018358 immunoglobulin Human genes 0.000 description 2
• 230000004054 inflammatory process Effects 0.000 description 2
• 238000011221 initial treatment Methods 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• DRAVOWXCEBXPTN-UHFFFAOYSA-N isoguanine Chemical compound NC1=NC(=O)NC2=C1NC=N2 DRAVOWXCEBXPTN-UHFFFAOYSA-N 0.000 description 2
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
• 229960000310 isoleucine Drugs 0.000 description 2
• 210000004698 lymphocyte Anatomy 0.000 description 2
• 210000003563 lymphoid tissue Anatomy 0.000 description 2
• 239000002207 metabolite Substances 0.000 description 2
• 229940035032 monophosphoryl lipid a Drugs 0.000 description 2
• 210000002487 multivesicular body Anatomy 0.000 description 2
• 238000006386 neutralization reaction Methods 0.000 description 2
• 208000002154 non-small cell lung carcinoma Diseases 0.000 description 2
• 108010067588 nucleotide pyrophosphatase Proteins 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 102000007863 pattern recognition receptors Human genes 0.000 description 2
• 108010089193 pattern recognition receptors Proteins 0.000 description 2
• 230000006320 pegylation Effects 0.000 description 2
• 230000002093 peripheral effect Effects 0.000 description 2
• 238000002823 phage display Methods 0.000 description 2
• 230000008782 phagocytosis Effects 0.000 description 2
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
• 150000008104 phosphatidylethanolamines Chemical class 0.000 description 2
• 150000004713 phosphodiesters Chemical class 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 230000000770 proinflammatory effect Effects 0.000 description 2
• 238000011321 prophylaxis Methods 0.000 description 2
• 210000003289 regulatory T cell Anatomy 0.000 description 2
• 230000009711 regulatory function Effects 0.000 description 2
• 208000002491 severe combined immunodeficiency Diseases 0.000 description 2
• 230000011664 signaling Effects 0.000 description 2
• 229940126586 small molecule drug Drugs 0.000 description 2
• 239000007858 starting material Substances 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 230000004083 survival effect Effects 0.000 description 2
• 125000003396 thiol group Chemical group [H]S* 0.000 description 2
• 210000001541 thymus gland Anatomy 0.000 description 2
• 238000013518 transcription Methods 0.000 description 2
• 230000035897 transcription Effects 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 238000013519 translation Methods 0.000 description 2
• 239000013638 trimer Substances 0.000 description 2
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
• XGOYIMQSIKSOBS-UHFFFAOYSA-N vadimezan Chemical compound C1=CC=C2C(=O)C3=CC=C(C)C(C)=C3OC2=C1CC(O)=O XGOYIMQSIKSOBS-UHFFFAOYSA-N 0.000 description 2
• 239000004474 valine Substances 0.000 description 2
• 230000009385 viral infection Effects 0.000 description 2
• HUUSXLKCTQDPGL-UHFFFAOYSA-N 1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[4-(2-hydroxypropan-2-yl)furan-2-yl]sulfonylurea Chemical compound CC(C)(O)C1=COC(S(=O)(=O)NC(=O)NC=2C=3CCCC=3C=C3CCCC3=2)=C1 HUUSXLKCTQDPGL-UHFFFAOYSA-N 0.000 description 1
• SWWQQSDRUYSMAR-UHFFFAOYSA-N 1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol;hydrochloride Chemical group Cl.C1=CC(O)=CC=C1CC1C2=CC(O)=C(O)C=C2CCN1 SWWQQSDRUYSMAR-UHFFFAOYSA-N 0.000 description 1
• XRILCFTWUCUKJR-INFSMZHSSA-N 2'-3'-cGAMP Chemical compound C([C@H]([C@H]1O)O2)OP(O)(=O)O[C@H]3[C@@H](O)[C@H](N4C5=NC=NC(N)=C5N=C4)O[C@@H]3COP(O)(=O)O[C@H]1[C@@H]2N1C=NC2=C1NC(N)=NC2=O XRILCFTWUCUKJR-INFSMZHSSA-N 0.000 description 1
• QZDDFQLIQRYMBV-UHFFFAOYSA-N 2-[3-nitro-2-(2-nitrophenyl)-4-oxochromen-8-yl]acetic acid Chemical compound OC(=O)CC1=CC=CC(C(C=2[N+]([O-])=O)=O)=C1OC=2C1=CC=CC=C1[N+]([O-])=O QZDDFQLIQRYMBV-UHFFFAOYSA-N 0.000 description 1
• ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 1
• ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
• 230000005730 ADP ribosylation Effects 0.000 description 1
• 229930024421 Adenine Natural products 0.000 description 1
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
• 102100034540 Adenomatous polyposis coli protein Human genes 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 241000004176 Alphacoronavirus Species 0.000 description 1
• 102100022749 Aminopeptidase N Human genes 0.000 description 1
• 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
• 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 101150076800 B2M gene Proteins 0.000 description 1
• 241000008904 Betacoronavirus Species 0.000 description 1
• 102100036301 C-C chemokine receptor type 7 Human genes 0.000 description 1
• 102100028990 C-X-C chemokine receptor type 3 Human genes 0.000 description 1
• 108010049990 CD13 Antigens Proteins 0.000 description 1
• 102100027207 CD27 antigen Human genes 0.000 description 1
• 108010029697 CD40 Ligand Proteins 0.000 description 1
• 102100032937 CD40 ligand Human genes 0.000 description 1
• 102100032912 CD44 antigen Human genes 0.000 description 1
• 102100022002 CD59 glycoprotein Human genes 0.000 description 1
• 108050007957 Cadherin Proteins 0.000 description 1
• 102000000905 Cadherin Human genes 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 108091026890 Coding region Proteins 0.000 description 1
• 102000000989 Complement System Proteins Human genes 0.000 description 1
• 108010069112 Complement System Proteins Proteins 0.000 description 1
• 102100025680 Complement decay-accelerating factor Human genes 0.000 description 1
• 102100030886 Complement receptor type 1 Human genes 0.000 description 1
• 241000314928 Cordyline virus 1 Species 0.000 description 1
• 241000699802 Cricetulus griseus Species 0.000 description 1
• IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
• 108010037897 DC-specific ICAM-3 grabbing nonintegrin Proteins 0.000 description 1
• 108010041986 DNA Vaccines Proteins 0.000 description 1
• 229940021995 DNA vaccine Drugs 0.000 description 1
• 241001461743 Deltacoronavirus Species 0.000 description 1
• 102100025137 Early activation antigen CD69 Human genes 0.000 description 1
• 102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 1
• 101710091045 Envelope protein Proteins 0.000 description 1
• 108010008177 Fd immunoglobulins Proteins 0.000 description 1
• 102100028071 Fibroblast growth factor 7 Human genes 0.000 description 1
• 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
• 241000008920 Gammacoronavirus Species 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 229930186217 Glycolipid Natural products 0.000 description 1
• 241000251728 Gnathostomata <vertebrate> Species 0.000 description 1
• 108060005986 Granzyme Proteins 0.000 description 1
• 102000001398 Granzyme Human genes 0.000 description 1
• 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 description 1
• 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 1
• 101710197836 HLA class I histocompatibility antigen, alpha chain G Proteins 0.000 description 1
• 102100031547 HLA class II histocompatibility antigen, DO alpha chain Human genes 0.000 description 1
• 102100029966 HLA class II histocompatibility antigen, DP alpha 1 chain Human genes 0.000 description 1
• 108010075704 HLA-A Antigens Proteins 0.000 description 1
• 108010058607 HLA-B Antigens Proteins 0.000 description 1
• 108010010378 HLA-DP Antigens Proteins 0.000 description 1
• 102000015789 HLA-DP Antigens Human genes 0.000 description 1
• 108010062347 HLA-DQ Antigens Proteins 0.000 description 1
• 108010058597 HLA-DR Antigens Proteins 0.000 description 1
• 102000006354 HLA-DR Antigens Human genes 0.000 description 1
• 230000010556 Heparin Binding Activity Effects 0.000 description 1
• 101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 description 1
• 101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 description 1
• 101000916050 Homo sapiens C-X-C chemokine receptor type 3 Proteins 0.000 description 1
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 1
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
• 101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 description 1
• 101000856022 Homo sapiens Complement decay-accelerating factor Proteins 0.000 description 1
• 101000727061 Homo sapiens Complement receptor type 1 Proteins 0.000 description 1
• 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 description 1
• 101000866278 Homo sapiens HLA class II histocompatibility antigen, DO alpha chain Proteins 0.000 description 1
• 101000864089 Homo sapiens HLA class II histocompatibility antigen, DP alpha 1 chain Proteins 0.000 description 1
• 101000930802 Homo sapiens HLA class II histocompatibility antigen, DQ alpha 1 chain Proteins 0.000 description 1
• 101000968032 Homo sapiens HLA class II histocompatibility antigen, DR beta 3 chain Proteins 0.000 description 1
• 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 1
• 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 1
• 101000868279 Homo sapiens Leukocyte surface antigen CD47 Proteins 0.000 description 1
• 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 1
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 1
• 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 1
• UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
• 208000034174 Immunodeficiency by defective expression of MHC class II Diseases 0.000 description 1
• 108700005091 Immunoglobulin Genes Proteins 0.000 description 1
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
• 102000016844 Immunoglobulin-like domains Human genes 0.000 description 1
• 108050006430 Immunoglobulin-like domains Proteins 0.000 description 1
• 108010034143 Inflammasomes Proteins 0.000 description 1
• UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
• 229930010555 Inosine Natural products 0.000 description 1
• 102100022339 Integrin alpha-L Human genes 0.000 description 1
• 102000008070 Interferon-gamma Human genes 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• 102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 description 1
• 102100033105 Interleukin-17C Human genes 0.000 description 1
• 102100030703 Interleukin-22 Human genes 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• 102100021592 Interleukin-7 Human genes 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• 125000000393 L-methionino group Chemical group [H]OC(=O)[C@@]([H])(N([H])[*])C([H])([H])C(SC([H])([H])[H])([H])[H] 0.000 description 1
• 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 108010006444 Leucine-Rich Repeat Proteins Proteins 0.000 description 1
• 102100032913 Leukocyte surface antigen CD47 Human genes 0.000 description 1
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 1
• 108700005089 MHC Class I Genes Proteins 0.000 description 1
• 108700005092 MHC Class II Genes Proteins 0.000 description 1
• 201000009635 MHC class II deficiency Diseases 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 101100328099 Mus musculus Clec9a gene Proteins 0.000 description 1
• 102100022691 NACHT, LRR and PYD domains-containing protein 3 Human genes 0.000 description 1
• 102000003945 NF-kappa B Human genes 0.000 description 1
• 108010057466 NF-kappa B Proteins 0.000 description 1
• PKFDLKSEZWEFGL-UHFFFAOYSA-N Nc1nc(=O)c2ncn(C3OC4COP(O)(=O)OC5C(COP(O)(=O)OC4C3O)OC(C5O)n3cnc4c3[nH]c(N)nc4=O)c2[nH]1 Chemical compound Nc1nc(=O)c2ncn(C3OC4COP(O)(=O)OC5C(COP(O)(=O)OC4C3O)OC(C5O)n3cnc4c3[nH]c(N)nc4=O)c2[nH]1 PKFDLKSEZWEFGL-UHFFFAOYSA-N 0.000 description 1
• 102000003729 Neprilysin Human genes 0.000 description 1
• 101710141454 Nucleoprotein Proteins 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 102000004503 Perforin Human genes 0.000 description 1
• 108010056995 Perforin Proteins 0.000 description 1
• KHGNFPUMBJSZSM-UHFFFAOYSA-N Perforine Natural products COC1=C2CCC(O)C(CCC(C)(C)O)(OC)C2=NC2=C1C=CO2 KHGNFPUMBJSZSM-UHFFFAOYSA-N 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 102100030090 Probable ATP-dependent RNA helicase DHX58 Human genes 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 1
• 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 1
• 101710188315 Protein X Proteins 0.000 description 1
• 108010059278 Pyrin Proteins 0.000 description 1
• 102000005583 Pyrin Human genes 0.000 description 1
• 108010001946 Pyrin Domain-Containing 3 Protein NLR Family Proteins 0.000 description 1
• 108020004511 Recombinant DNA Proteins 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
• 241001222774 Salmonella enterica subsp. enterica serovar Minnesota Species 0.000 description 1
• 239000002262 Schiff base Substances 0.000 description 1
• 150000004753 Schiff bases Chemical class 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 101000596375 Severe acute respiratory syndrome coronavirus 2 ORF7b protein Proteins 0.000 description 1
• 101000992426 Severe acute respiratory syndrome coronavirus 2 ORF9b protein Proteins 0.000 description 1
• 101001086079 Severe acute respiratory syndrome coronavirus 2 Putative ORF3b protein Proteins 0.000 description 1
• 101000992423 Severe acute respiratory syndrome coronavirus 2 Putative ORF9c protein Proteins 0.000 description 1
• 102100038081 Signal transducer CD24 Human genes 0.000 description 1
• 108010003723 Single-Domain Antibodies Proteins 0.000 description 1
• 101800000905 Spike protein S2 Proteins 0.000 description 1
• 229930182558 Sterol Natural products 0.000 description 1
• 101710172711 Structural protein Proteins 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 1
• 210000004241 Th2 cell Anatomy 0.000 description 1
• 108020004566 Transfer RNA Proteins 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102100040247 Tumor necrosis factor Human genes 0.000 description 1
• 102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 description 1
• 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 1
• IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 1
• 229930003427 Vitamin E Natural products 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 239000008186 active pharmaceutical agent Substances 0.000 description 1
• 230000010933 acylation Effects 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 229960000643 adenine Drugs 0.000 description 1
• 230000009824 affinity maturation Effects 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical group [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
• 230000009435 amidation Effects 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• 150000001412 amines Chemical group 0.000 description 1
• 210000001776 amniocyte Anatomy 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 230000000844 anti-bacterial effect Effects 0.000 description 1
• 230000003302 anti-idiotype Effects 0.000 description 1
• 230000000692 anti-sense effect Effects 0.000 description 1
• 230000000259 anti-tumor effect Effects 0.000 description 1
• 230000014102 antigen processing and presentation of exogenous peptide antigen via MHC class I Effects 0.000 description 1
• 230000001640 apoptogenic effect Effects 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 230000010516 arginylation Effects 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 230000005784 autoimmunity Effects 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 230000008512 biological response Effects 0.000 description 1
• 239000000090 biomarker Substances 0.000 description 1
• ACBQROXDOHKANW-UHFFFAOYSA-N bis(4-nitrophenyl) carbonate Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC(=O)OC1=CC=C([N+]([O-])=O)C=C1 ACBQROXDOHKANW-UHFFFAOYSA-N 0.000 description 1
• 238000006664 bond formation reaction Methods 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• 238000004422 calculation algorithm Methods 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 201000011510 cancer Diseases 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 230000022534 cell killing Effects 0.000 description 1
• 230000004640 cellular pathway Effects 0.000 description 1
• 230000036755 cellular response Effects 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 238000001311 chemical methods and process Methods 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 150000001841 cholesterols Chemical class 0.000 description 1
• 230000007748 combinatorial effect Effects 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 230000001268 conjugating effect Effects 0.000 description 1
• 239000000356 contaminant Substances 0.000 description 1
• 238000004132 cross linking Methods 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 210000004748 cultured cell Anatomy 0.000 description 1
• 229940095074 cyclic amp Drugs 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 210000005220 cytoplasmic tail Anatomy 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000007123 defense Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 238000002298 density-gradient ultracentrifugation Methods 0.000 description 1
• 229910003460 diamond Inorganic materials 0.000 description 1
• 239000010432 diamond Substances 0.000 description 1
• 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 210000003386 epithelial cell of thymus gland Anatomy 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 210000003722 extracellular fluid Anatomy 0.000 description 1
• 238000011354 first-line chemotherapy Methods 0.000 description 1
• 210000003953 foreskin Anatomy 0.000 description 1
• 230000022244 formylation Effects 0.000 description 1
• 238000006170 formylation reaction Methods 0.000 description 1
• 230000037433 frameshift Effects 0.000 description 1
• 230000006251 gamma-carboxylation Effects 0.000 description 1
• 210000004475 gamma-delta t lymphocyte Anatomy 0.000 description 1
• WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 210000001280 germinal center Anatomy 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 150000002327 glycerophospholipids Chemical class 0.000 description 1
• 238000011194 good manufacturing practice Methods 0.000 description 1
• 239000005090 green fluorescent protein Substances 0.000 description 1
• 150000003278 haem Chemical group 0.000 description 1
• 244000000013 helminth Species 0.000 description 1
• 210000002443 helper t lymphocyte Anatomy 0.000 description 1
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 230000033444 hydroxylation Effects 0.000 description 1
• 238000005805 hydroxylation reaction Methods 0.000 description 1
• 238000001597 immobilized metal affinity chromatography Methods 0.000 description 1
• 230000002519 immonomodulatory effect Effects 0.000 description 1
• 230000008105 immune reaction Effects 0.000 description 1
• 238000009169 immunotherapy Methods 0.000 description 1
• 230000006759 inflammatory activation Effects 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 229960003786 inosine Drugs 0.000 description 1
• 238000003780 insertion Methods 0.000 description 1
• 230000037431 insertion Effects 0.000 description 1
• 230000035992 intercellular communication Effects 0.000 description 1
• 229960003130 interferon gamma Drugs 0.000 description 1
• 108010074108 interleukin-21 Proteins 0.000 description 1
• 108010074109 interleukin-22 Proteins 0.000 description 1
• 239000000543 intermediate Substances 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000010253 intravenous injection Methods 0.000 description 1
• 230000026045 iodination Effects 0.000 description 1
• 238000006192 iodination reaction Methods 0.000 description 1
• NBQNWMBBSKPBAY-UHFFFAOYSA-N iodixanol Chemical compound IC=1C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C(I)C=1N(C(=O)C)CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NBQNWMBBSKPBAY-UHFFFAOYSA-N 0.000 description 1
• 229960004359 iodixanol Drugs 0.000 description 1
• PGHMRUGBZOYCAA-UHFFFAOYSA-N ionomycin Natural products O1C(CC(O)C(C)C(O)C(C)C=CCC(C)CC(C)C(O)=CC(=O)C(C)CC(C)CC(CCC(O)=O)C)CCC1(C)C1OC(C)(C(C)O)CC1 PGHMRUGBZOYCAA-UHFFFAOYSA-N 0.000 description 1
• PGHMRUGBZOYCAA-ADZNBVRBSA-N ionomycin Chemical compound O1[C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)/C=C/C[C@@H](C)C[C@@H](C)C(/O)=C/C(=O)[C@@H](C)C[C@@H](C)C[C@@H](CCC(O)=O)C)CC[C@@]1(C)[C@@H]1O[C@](C)([C@@H](C)O)CC1 PGHMRUGBZOYCAA-ADZNBVRBSA-N 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 210000004901 leucine-rich repeat Anatomy 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 230000021633 leukocyte mediated immunity Effects 0.000 description 1
• 108010052322 limitin Proteins 0.000 description 1
• GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical class O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 230000033001 locomotion Effects 0.000 description 1
• 210000005265 lung cell Anatomy 0.000 description 1
• 210000002751 lymph Anatomy 0.000 description 1
• 210000001165 lymph node Anatomy 0.000 description 1
• 210000003712 lysosome Anatomy 0.000 description 1
• 230000001868 lysosomic effect Effects 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 230000001617 migratory effect Effects 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 230000009149 molecular binding Effects 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 210000002864 mononuclear phagocyte Anatomy 0.000 description 1
• 210000004877 mucosa Anatomy 0.000 description 1
• 230000000869 mutational effect Effects 0.000 description 1
• 230000007498 myristoylation Effects 0.000 description 1
• 210000000581 natural killer T-cell Anatomy 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 230000003472 neutralizing effect Effects 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 238000006384 oligomerization reaction Methods 0.000 description 1
• 230000003571 opsonizing effect Effects 0.000 description 1
• 210000003463 organelle Anatomy 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 229930192851 perforin Natural products 0.000 description 1
• 210000001539 phagocyte Anatomy 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 238000009521 phase II clinical trial Methods 0.000 description 1
• 102000005309 phosducin Human genes 0.000 description 1
• 108010031256 phosducin Proteins 0.000 description 1
• 150000008106 phosphatidylserines Chemical class 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 230000010399 physical interaction Effects 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 229920002704 polyhistidine Polymers 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 230000013823 prenylation Effects 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• 238000004393 prognosis Methods 0.000 description 1
• 210000001236 prokaryotic cell Anatomy 0.000 description 1
• 230000004853 protein function Effects 0.000 description 1
• 230000004844 protein turnover Effects 0.000 description 1
• 230000002797 proteolythic effect Effects 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• 150000003212 purines Chemical class 0.000 description 1
• 229940043131 pyroglutamate Drugs 0.000 description 1
• 230000006340 racemization Effects 0.000 description 1
• 238000002708 random mutagenesis Methods 0.000 description 1
• 230000008707 rearrangement Effects 0.000 description 1
• 230000003134 recirculating effect Effects 0.000 description 1
• 150000004492 retinoid derivatives Chemical class 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 238000007363 ring formation reaction Methods 0.000 description 1
• 210000005212 secondary lymphoid organ Anatomy 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 238000000527 sonication Methods 0.000 description 1
• 150000003408 sphingolipids Chemical class 0.000 description 1
• 230000007480 spreading Effects 0.000 description 1
• 238000003892 spreading Methods 0.000 description 1
• 235000003702 sterols Nutrition 0.000 description 1
• 150000003432 sterols Chemical class 0.000 description 1
• 230000019635 sulfation Effects 0.000 description 1
• 238000005670 sulfation reaction Methods 0.000 description 1
• 229920001059 synthetic polymer Polymers 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
• 230000003614 tolerogenic effect Effects 0.000 description 1
• 229940043263 traditional drug Drugs 0.000 description 1
• 102000035160 transmembrane proteins Human genes 0.000 description 1
• 108091005703 transmembrane proteins Proteins 0.000 description 1
• 238000011277 treatment modality Methods 0.000 description 1
• 230000004614 tumor growth Effects 0.000 description 1
• 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
• 238000010798 ubiquitination Methods 0.000 description 1
• 230000034512 ubiquitination Effects 0.000 description 1
• 229950008737 vadimezan Drugs 0.000 description 1
• 230000035899 viability Effects 0.000 description 1
• 230000029812 viral genome replication Effects 0.000 description 1
• 244000052613 viral pathogen Species 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 235000019165 vitamin E Nutrition 0.000 description 1
• 239000011709 vitamin E Substances 0.000 description 1
• 229940046009 vitamin E Drugs 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
• 229940075420 xanthine Drugs 0.000 description 1